Article
Targeted expression of the dominant-negative prolactin receptor in the mammary gland of transgenic mice results in impaired lactation.
Endocrinology - 1 Jun 2003
Saunier Elise, Dif Fariel, Kelly Paul A, Edery Marc
Abstract excerpt
The F3-short form of the rat PRL receptor (F3-SPRLR) form acts as a dominant negative inhibitor in vitro. We have developed a transgenic mouse model in which the rat F3-SPRLR was expressed in mammary epithelium under the control of the mouse mammary tumor virus promoter. Two lines of mice were characterized and shown to express the transgene in the mammary gland. No developmental abnormalities or differences from...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
